Latest News

Nvidia has received U.S. approval to resume shipments of its H200 AI chips to commercial customers in China from mid-February 2026, reopening access to a key market that had been constrained by export controls. This decision revives what analysts had viewed as a rapidly growing China AI opportunity, potentially reshaping Nvidia’s long-term demand mix and regional exposure just as global AI infrastructure spending scales up. With H200 shipments to China back on the table, we’ll examine how...

Pitney Bowes has recently completed and upsized its cash tender offers for outstanding notes, using US$79.9 million to retire part of its long-term debt and increasing the purchase cap from US$75 million to US$80 million to accept all valid tenders. By using cash to retire long-dated notes and refine its capital structure, the company is signaling a focus on balance sheet improvement and more disciplined capital allocation. We’ll now examine how Pitney Bowes’ decision to retire US$79.9...

Altius Minerals (TSX:ALS) has quietly turned into a strong long term performer, with the stock up around 21% over the past 3 months and roughly 49% over the past year. See our latest analysis for Altius Minerals. With the share price now at $39.57, that strong 90 day share price return and standout five year total shareholder return suggest momentum is still building as investors reassess Altius Minerals growth prospects and risk profile. If Altius has you rethinking what sustained...

Stifel Financial (SF) just posted record client assets for November, with total assets up 8% and fee based assets up 14% year over year. This has been a key driver behind the stock’s recent momentum. See our latest analysis for Stifel Financial. That backdrop of record client assets has helped fuel a clear upswing in sentiment, with a roughly 10% 1 month share price return and a powerful 135.8% three year total shareholder return suggesting momentum is still building rather than fading. If...

Park Hotels & Resorts (PK) has quietly lagged the broader market this year, and that underperformance has investors asking whether the stock is now a value opportunity or a value trap. See our latest analysis for Park Hotels & Resorts. At around $10.79, Park Hotels & Resorts reflects a year to date share price return of negative 21.7 percent. Its three year total shareholder return of 28.3 percent suggests longer term holders have still come out ahead, which may indicate that recent weakness...

Hafnia (OB:HAFNI) has quietly slipped over the past month, with the share price down around 16% even as its longer term 3 year return sits above 60%. That gap is worth unpacking. See our latest analysis for Hafnia. The recent pullback, including a 16.4 percent 30 day share price return and weaker year to date performance, looks more like fading momentum after an exceptional three year total shareholder return than a fundamental reset. If Hafnia has you thinking about where else shipping...

Perpetua Resources Corp. recently announced that it selected Hatch Ltd. as EPCM contractor for the Stibnite Gold Project and agreed a roughly US$4.00 million private placement at US$28.84 per share, while also partnering with Idaho National Laboratory to pilot processing of antimony for defense uses. This combination of an experienced EPCM partner, fresh project funding, and a government-linked pilot plant underscores Stibnite’s role in domestic antimony supply and mine-site restoration...

Mineral Resources recently reported record quarterly shipments and confirmed its Onslow Iron project is operating at its 35Mtpa nameplate capacity, while benefiting from a rebound in lithium prices linked to supply disruptions in China. This combination of fully ramped iron ore operations and renewed lithium market optimism has reinforced investor focus on the company’s dual exposure to steelmaking and battery metals demand. Now we’ll explore how achieving nameplate capacity at Onslow Iron...

Praxis Precision Medicines recently completed a Type C meeting with the FDA, securing agreement to convert its EMBRAVE3 trial of elsunersen for early-onset SCN2A developmental and epileptic encephalopathy into a smaller, single-arm, baseline-controlled study focused on seizure reduction over 24 weeks plus an open-label extension. This shift, alongside prior orphan and rare pediatric designations, underscores elsunersen’s potential as a disease-modifying therapy in an ultra-rare, genetically...

In the past week, Enerpac Tool Group Corp. reported Q1 2026 results showing sales of US$144.21 million and net income of US$19.13 million, slightly below the prior year, alongside basic and diluted EPS of US$0.36 from continuing operations. Alongside modestly lower earnings, Enerpac completed a multi-year share repurchase of 9,359,151 shares for US$253.93 million, while highlighting 4% organic product growth and heavy lifting strength, underlining a focus on capital returns and higher-value...

Earlier in 2025, ADMA Biologics raised its 2025 revenue outlook to US$510 million, up from prior guidance of more than US$500 million, while modestly revising adjusted net income expectations to reflect a higher effective tax rate. This updated guidance highlights management’s confidence in the performance of BIVIGAM and Nabi-HB and offers investors clearer visibility into the company’s near-term earnings profile. Next, we’ll explore how this higher 2025 revenue guidance refines ADMA...

Anritsu (TSE:6754) has quietly delivered a strong run lately, with the share price climbing about 4% over the past month and roughly 15% in the past 3 months. That kind of steady momentum naturally raises the question of whether the market is simply catching up to fundamentals or starting to look ahead to the next wave of 5G and 6G driven demand. See our latest analysis for Anritsu. Zooming out, that recent strength sits on top of a much bigger move. The year to date share price return is...

On December 11, 2025, NiSource Inc. entered into a Seventh Amended and Restated Revolving Credit Agreement, lifting its revolving credit facility by US$650 million to US$2.50 billion, extending the termination date to December 11, 2030, and expanding standby letter of credit capacity to US$175 million while revising several covenant thresholds. By enlarging and extending this core credit facility and removing ESG-linked rate adjustments, NiSource has materially increased its financial...

Upstream Bio (UPB) just earned a spot in the NASDAQ Biotechnology Index, a visibility upgrade that can quietly reshape its investor base, trading volume, and how the market values its pipeline. See our latest analysis for Upstream Bio. That index inclusion lands on top of already strong momentum, with the share price at $30.43 and an 86.92% 3 month share price return that suggests investors are re-rating its risk and growth profile rather than just reacting to a one day move. If this kind of...

Koninklijke BAM Groep nv's ( AMS:BAMNB ) price-to-earnings (or "P/E") ratio of 22.4x might make it look like a sell...

Pricer AB (publ) ( STO:PRIC B ) shareholders should be happy to see the share price up 13% in the last week. But that...

Despite an already strong run, Sphere Entertainment Co. ( NYSE:SPHR ) shares have been powering on, with a gain of 25...

Oscar Health (OSCR) is back in focus after fresh analysis flagged rising regulatory and competitive risks, especially in Georgia, where shifting enrollment patterns could pressure margins and reshape how investors think about the stock. See our latest analysis for Oscar Health. The latest regulatory jitters have landed just as Oscar’s 1 month share price return of 11.50 percent and year to date share price return of 10.92 percent signal a tentative recovery, while its 3 year total shareholder...

Recently, commentary on Alamo Group highlighted strong growth in its Industrial Equipment segment alongside further weakness in Vegetation Management, reflecting uneven demand across its end markets. This split performance underscores how reliance on healthier infrastructure-related spending contrasts with softer vegetation markets, raising questions about the balance of future earnings drivers. Next, we’ll explore how this ongoing Vegetation Management softness affects Alamo Group’s...

JetBlue has opened BlueHouse, its first airport lounge, at JFK Terminal 5 and continued expanding its Florida and East Coast network, including new routes to Vero Beach and additional Northeast–Florida services, while also updating its corporate bylaws to modernize shareholder procedures and governance protections. The launch of BlueHouse as a perk for top-tier loyalty members and JetBlue Premier cardholders highlights a shift toward premium, higher-value customers that could influence how...

Aveanna Healthcare Holdings (AVAH) has quietly delivered a strong run over the past year, nearly doubling in value, as investors warm to its steady revenue growth and improving profitability in home based care. See our latest analysis for Aveanna Healthcare Holdings. That strength is showing up clearly in the tape, with the share price now at $8.93 and a near doubling year to date on a share price return basis. The three year total shareholder return of over 1,000 percent signals powerful,...

On December 15, 2025, CSW Industrials increased its equity buyback authorization by US$50 million to a total of US$250 million, signaling a larger capital allocation toward repurchases. This expansion of the repurchase plan comes on the back of multi-year compounded growth in sales and earnings per share, supported by strong free cash flow margins. Next, we’ll examine how this expanded buyback authorization, alongside robust long-term growth metrics, may influence CSW Industrials’ investment...

AeroVironment (AVAV) just caught fresh attention after KeyBanc initiated coverage with an upbeat view on its role in defense technology and space, helping the stock climb even as recent earnings and guidance remained mixed. See our latest analysis for AeroVironment. The latest 1 day share price gain of 5.09 percent to 255.39 dollars caps a volatile few months. Recent contract wins in lasers, maritime robotics, and electronic warfare have offset earlier weakness, and the 1 year total...

Ryder System (R) has been climbing on a wave of upbeat Wall Street coverage, as several major firms express confidence in its outlook, even while recent boardroom changes remain more of a background governance story. See our latest analysis for Ryder System. Those upbeat calls appear to be landing with investors, with Ryder’s share price at $195.18 after a 16.01 percent 30 day share price return and a powerful 253.31 percent five year total shareholder return, suggesting momentum is still...